MYCOF

Mydecine Innovations (PK) Stock Price

0.3808
0.0058 (1.55%)
0.3808
Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
VAT not included
Company Name Stock Ticker Symbol Market Type
Mydecine Innovations Group Inc (PK) MYCOF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
0.0058 1.55% 0.3808 0.35 0.4275 0.35 0.375 16:16:09
Bid Price Ask Price Spread Spread % News
0.36 0.42 0.06 14.29% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
121 378,270 $ 0.393472 $ 148,838 99,326 0.3185 - 0.664
Last Trade Time Type Quantity Stock Price Currency
15:43:27 453 $ 0.3808 USD

Mydecine Innovations (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 55.63M 146.08M - $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
11.00 $ - 0.00% - -

more financials information »

Mydecine Innovations (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MYCOF Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.38040.4540.31850.385050157,8460.00040.11%
1 Month0.5540.59190.31850.424012263,693-0.1732-31.26%
3 Months0.610.6640.31850.524886492,583-0.2292-37.57%
6 Months0.610.6640.31850.524886492,583-0.2292-37.57%
1 Year0.610.6640.31850.524886492,583-0.2292-37.57%
3 Years0.610.6640.31850.524886492,583-0.2292-37.57%
5 Years0.610.6640.31850.524886492,583-0.2292-37.57%

Mydecine Innovations (PK) Description

Mydecine Innovations Group is a life sciences company dedicated to the development and commercialization of adaptive pathway medicines, natural health products and digital health solutions. Mydecine’s experienced cross functional teams have the capabilities to oversee all areas of drug development including synthesis, drug delivery system development, clinical trial execution, through to product commercialization and marketing. By leveraging strategic partnerships with scientific, medical, military, and clinical organizations Mydecine is at the forefront of the efficient development of psychedelic derived medicines and therapeutic solutions. Our trailblazing portfolio of companies is focused on providing innovative and effective treatment options that can help millions of people live healthier lives.


Your Recent History
USOTC
MYCOF
Mydecine I..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.